Dialybrid S.r.l.
PrivateLast Round
Series A
Sep 22, 2026
Total Funding Raised
$17.55M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Dialybrid S.r.l. operates in Healthcare & Life Sciences and is based in Cantù. Its latest recorded funding round was a Series A round in September 2026.
Dialybrid S.r.l. is a medical device company that develops and commercializes novel arteriovenous vascular grafts for hemodialysis using its proprietary Silkothane® technology.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Advanced Materials, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Dialybrid S.r.l. Comparables
Compare Dialybrid S.r.l. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Anova Biomedical | 86% | |
| Lingbo Biotechnology (Hangzhou) Co., Ltd. | 84% | |
| Xeltis | 78% |
For institutional investors. Book with your work email.
Dialybrid S.r.l. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 22, 2026 | ||||
| Seed | Aug 4, 2020 |
For institutional investors. Book with your work email.
Dialybrid S.r.l. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| XGEN Venture | Series A |
| CDP Venture Capital SGR | Series A |
| LIFTT EuroInvest | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 22, 2026
$17M round led by XGEN Venture.
- Aug 4, 2020
$350K round led by LIFTT EuroInvest
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingSep 22, 2026
Dialybrid is developing a novel vascular access solution for hemodialysis based on Silkothane, with its first-in-human trial enrolling in Italy and the first patient successfully implanted on Sep 22nd '26.
- receives_financingSep 22, 2026
Dialybrid receives $17.2M Series A financing in Italy on Sep 22nd '26, in a round led by XGEN Venture with participation from CDP Venture Capital’s Rilancio Fund to fund clinical validation of its Silkothane(R) arteriovenous graft and preclinical development of the Silkothane(R) material for other vascular applications.
- attends_eventSep 22, 2026
Dialybrid will be attending LSI Europe '26 Emerging MedTech Summit in Spain on Sep 29th '26 and Sep 30th '26, where its CTO will present the company and participate in a panel discussion.
For institutional investors. Book with your work email.
Dialybrid S.r.l. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Dialybrid S.r.l.'s valuation, stock price, and market status.
Is Dialybrid S.r.l. a public or private company?
Dialybrid S.r.l. is a private company.
What is the current stock price of Dialybrid S.r.l.?
Dialybrid S.r.l. is a private company, so its shares have no public market price. Caplight tracks Dialybrid S.r.l.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Dialybrid S.r.l. worth (valuation)?
Valuation information for Dialybrid S.r.l. is not publicly available.
Can I buy Dialybrid S.r.l. stock?
Dialybrid S.r.l. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Dialybrid S.r.l.'s last funding round?
Dialybrid S.r.l.'s most recent funding round was Series A on September 22, 2026.
Who are the main investors in Dialybrid S.r.l.?
Key investors in Dialybrid S.r.l. include XGEN Venture, LIFTT EuroInvest.
Will Dialybrid S.r.l. IPO soon?
No public IPO plans have been announced for Dialybrid S.r.l..
How can I track Dialybrid S.r.l. secondary market activity?
Caplight tracks bids, offers, and trades in Dialybrid S.r.l.'s shares on secondary markets.